| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,305 | +2.03% | |
| 6 months | ₹30,000 | ₹32,602 | +8.67% | |
| 1 year | ₹60,000 | ₹68,649 | +14.41% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Laurus Labs Ltd | Healthcare | Equity | 11.23% |
| Lupin Ltd | Healthcare | Equity | 8.01% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 7.16% |
| Fortis Healthcare Ltd | Healthcare | Equity | 7.12% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 5.63% |
| Alkem Laboratories Ltd | Healthcare | Equity | 4.70% |
| Biocon Ltd | Healthcare | Equity | 4.43% |
| Ipca Laboratories Ltd | Healthcare | Equity | 4.13% |
| Mankind Pharma Ltd. | Healthcare | Equity | 4.11% |
| Gland Pharma Ltd | Healthcare | Equity | 3.46% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 3.05% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 3.03% |
| Neuland Laboratories Ltd | Healthcare | Equity | 2.99% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 2.95% |
| Ami Organics Ltd | Healthcare | Equity | 2.47% |
| Wockhardt Ltd | Healthcare | Equity | 2.34% |
| Ajanta Pharma Ltd | Healthcare | Equity | 2.29% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 2.27% |
| Abbott India Ltd | Healthcare | Equity | 2.03% |
| Piramal Pharma Ltd | Healthcare | Equity | 2.01% |
| Narayana Hrudayalaya Ltd | Healthcare | Equity | 1.99% |
| Global Health Ltd | Healthcare | Equity | 1.91% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 1.90% |
| Granules India Ltd | Healthcare | Equity | 1.81% |
| Onesource Specialty Pharma Ltd | Healthcare | Equity | 1.80% |
| Syngene International Ltd | Healthcare | Equity | 1.15% |
| Natco Pharma Ltd | Healthcare | Equity | 1.14% |
| Suven Pharmaceuticals Ltd | Healthcare | Equity | 1.12% |
| Pfizer Ltd | Healthcare | Equity | 1.07% |
| Poly Medicure Ltd | Healthcare | Equity | 1.01% |
| Net Payables | Unspecified | Net Payables | -0.31% |
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +8.9% | +19.1% | +15.7% | +26.2% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 15 | 11 | 13 | -- |